MarketersMEDIA / Newsroom / Botulinum toxin Market – Global Industry Analysis, Trends, Size, Share and Forecast 2018 to 2026

Botulinum toxin Market – Global Industry Analysis, Trends, Size, Share and Forecast 2018 to 2026

Share This Press Release

The botulinum toxin market was valued at US$ 3,672.4 Mn in 2017 and expected to grow at a CAGR of 7.2 % during the forecast period from 2018 to 2026.

— The latest market report published by Credence Research, Inc. "Botulinum toxin Market: Growth, Future Prospects, and Competitive Analysis, 2018 -2026" The botulinum toxin market was estimated at US$3,672.4 million in 2017 and expected to grow at a CAGR of 7.2% over the forecast period from 2018 to 2026.

**By Product Type: Botulinum Toxin A (BNT-A), Botulinum Toxin B (BNT-B)
**By Application: Cosmetics, Neurological Disorders, Other Therapeutic Areas
**By End User: Hospitals, Dermatology & Beauty Clinics, Spas & Cosmetic Centers

Market Insights
During the forecast period from 2018 to 2026, the global botulinum toxin market shows productive growth due to its wide use in cosmetic and therapeutic applications. Botulinum toxin A (BNT-A) and botulinum toxin B (BNT-B) are common types. Botox injections or drugs from a neurotoxin produced by the bacterium clostridium botulinum. Doctors or dermatology specialists use botulinum toxins in very small doses to treat numerous health problems such as facial wrinkle smoothing, cervical dystonia (neurological disorder), blepharospasm, overactive bladder, upper limb or lower limb spasticity, strabism, tremor, hypersecretory disorders and others. BNT Type A trade names in the U.S. are mainly sold as Botox, Dysport and Xeomin (commercially available) and type B trade names are Myobloc and Neurobloc. Botulinum toxin B is U.S FDA approved for treatment against cervical dystonia and hemifacial spasm (HFS).

Browse the full report Botulinum Toxin Market Growth, Future Prospects, and Competitive Analysis, 2018 - 2026 at https://www.credenceresearch.com/report/botulinum-toxin-market

Consistent innovation along with top cosmetic applications to deliver productive restorative intervention to a large group of diseases has supported overall market growth. A few botulinum toxins (BNT) are in the clinical stage and are expected to drive the market in the coming years. The prominent growth factors include increasing cosmetic and therapeutic procedures worldwide, FDA approval of botulinum treatments, increased efficacy, increased geriatric population, increased awareness, potential advantage as an elective treatment for high-cost medical / surgical procedures, and wide use of top applications in the cosmetic industry.

In any case, the key components that limit market growth during the forecast period are safety issues in treatment and overall potential lethality, high financial investment and expensive medicines, strict administrative rules, and reimbursement approach issues. In addition, the worldwide monetary conditions in the healthcare sector in developing economies make a noteworthy open door for market expansion.

Key Market Movements:
*Globally, the botulinum toxin market remains showing profitable growth with a CAGR of 7.2 percent for the period from 2018 to 2026
*The BNT type A segment shows lucrative growth with increasing applications in the cosmetic and therapeutic procedures
*The development of the worldwide botulinum toxin market is mainly  attributed to the high pervasiveness of neurological disorders, higher adoption of BNT injections in the end-user segment and higher technological advances in products, with increased efficacy and lower side effects during treatment.
*North America's maximum revenue share in the overall growth of the botulinum toxin market, attributed to rising cosmetic & surgical procedures, the broad use of BNT type A & B in the treatment of cosmetic applications such as front lines, crow's feet, square jaw / masseter, frown lines and others
*Increasing awareness and programs held by top trained and skilled dermatology professionals, maximum reimbursement coverage, increasing inclination towards cosmetic procedures, ageing population and the presence of top key botulinum manufacturers & sophisticated healthcare infrastructure in the developing nations are few of the external factors driving the growth of the market.
*Eastern Europe, Latin America and Asia-Pacific show promising opportunities and demonstrate growing CAGR over the forecast period due to increased awareness among individuals of the concerns and use of botulinum toxin
*Surging population & growing number of advanced healthcare settings, availability of branded product types, and increasing healthcare spending in Russia, Brazil, India, China, and Japan may contribute the growth of the market during the forecast period
*Major players in this vertical are Allergan Plc., Speywood Pharmaceuticals, Merz Pharma GmbH & Co. KGaA, Lanzhou Biological Products Institute, Elan Pharmaceuticals, Revance Therapeutics, Inc., Medytox, Inc., US Worldmeds, LLC, Lanzhou Institute of Biological Products Co. Ltd. Ipsen Group and others.

Get Sample (Free) @ https://www.credenceresearch.com/sample-request/59070

ToC:
Chapter 1. Preface
..............
Chapter 2. Executive Summary
..............
Chapter 3. Global Botulinum Toxin Market: Market Dynamics and Future Outlook
................
Chapter 4. Global Botulinum Toxin Market, by Product Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Botulinum toxin A (BNT-A)
4.3. Botulinum toxin B (BNT-B)

Chapter 5. Global Botulinum Toxin Market, By Application, 2016 – 2026 (US$)
5.1. Overview
5.2. Cosmetics
5.3. Neurological Disorders
5.4. Other Therapeutic Areas

Chapter 6. Global Botulinum Toxin Market, By End User, 2016 – 2026 (US$)
6.1. Overview
6.2. Hospitals
6.3. Dermatology & Beauty Clinics
6.4. Spas & Cosmetic Centers

Chapter 7. Global Botulinum Toxin Market, by Geography, 2016 – 2026 (US$ Mn)
..............
Chapter 8. Company Profiles
8.1. Allergan Plc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Speywood Pharmaceuticals
8.3. Merz Pharma GmbH & Co. KGaA
8.4. Elan Pharmaceuticals
8.5. Revance Therapeutics, Inc.
8.6. Medytox, Inc.
8.7. US Worldmeds,LLC
8.8. Lanzhou Institute of Biological Products Co.Ltd.
8.9. Ipsen Group

Browse the full report Botulinum Toxin Market Growth, Future Prospects, and Competitive Analysis, 2018 - 2026 at https://www.credenceresearch.com/report/botulinum-toxin-market

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com

Source URL: https://marketersmedia.com/botulinum-toxin-market-global-industry-analysis-trends-size-share-and-forecast-2018-to-2026/495557

Source: MarketersMedia

Release ID: 495557

Subscribe and Receive exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2019 MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).